InterVenn Biosciences
1 follower
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together wi... Read more
Org chart
Joshua Stahl
CEO
Joshua Stahl
Collapse
Ada Wong
VP, Intellectual Property
Dan Serie
VP, Bioinformatics & Data Science
Kaitlynn Moser
VP, Clinical Development
Kim MacMartin-Moglia
VP of Business Development
Fadzhari Jabar
GM, Malaysia & VP, Business Development
Andrew Quong
EVP And GM
Jonathan Hirokawa
Senior Data Engineer
